By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
Keyword(s):
NA
2016 ◽
Vol 16
(4)
◽
pp. 233-237
◽
2017 ◽
Vol 18
(13)
◽
pp. 1357-1362
◽
2021 ◽
Vol 19
(3.5)
◽
pp. BPI21-008
2016 ◽
Vol 12
(11)
◽
pp. 1148-1156
◽
2016 ◽
2017 ◽
Vol 147
(1)
◽
pp. 153-157
◽
2017 ◽
Vol 75
◽
pp. 116-123
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 658-658
◽